# Long-term Characterization of Lipoprotein Apheresis Technologies for Individual Device Adaption (LOLIDA)

> **NCT05181969** · — · UNKNOWN · sponsor: **Technische Universität Dresden** · enrollment: 500 (estimated)

## Conditions studied

- Lipoproteinemia
- Apheresis Related Complication
- Cardiovascular Diseases

## Interventions

- **DEVICE:** Dextran sulfate absorption (LIPOSORBER® D - Kaneka Pharma Europe NV)
- **DEVICE:** Lipid filtration (Octo Nova®, Diamed Medizintechnik)
- **DEVICE:** Direct absorption of lipoproteins (DALI®; ADS 4008, Fresenius)
- **DEVICE:** Therasorb (TheraSorb® - LDL adsorbers, Miltenyi Biotec)

## Key facts

- **NCT ID:** NCT05181969
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05181969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05181969, "Long-term Characterization of Lipoprotein Apheresis Technologies for Individual Device Adaption (LOLIDA)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05181969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*